Researchers at MIT and Harvard Medical School have identified a compound that interferes with the pathogenic effects of Huntington’s disease, a discovery that could lead to development of a new treatment for the disease.
Researchers at MIT and Harvard Medical School have identified a compound that interferes with the pathogenic effects of Huntington’s disease, a discovery that could lead to development of a new treatment for the disease.
